Poziotinib Completed Phase 2 Trials for Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Head and Neck Neoplasms Prevention

IndicationsStatusPurposePhase
CompletedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03292250Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]